Companies > U.S. Pharmacopeia

New hires at U.S. Pharmacopeia

  • Lucy Botros

    Scientist III

    Lucy Botros

    Came from...

    Molecular Biometrics Inc, Research Scientist and Operations Manager

  • Shiow-Jyi Wey

    Reference Standards Scientist

    Shiow-Jyi Wey

    Came from...

    PCI Synthesis, Sr Research Scientist (Temp)

  • Claire Chisolm

    Scientist III

    Claire Chisolm

    Came from...

    Midwest Research Institute, Staff Chemist

  • Brian Jackson

    Associate Bulk Procurement Specialist

    Brian Jackson

    Came from...

    Unilever Global, Procurement Operations

  • Jeffrey Palombo

    Reference Standard Scientist III

    Jeffrey Palombo

    Came from...

    Human Genome Sciences, Research Associate III

See all activity »

U.S. Pharmacopeia Activity on LinkedIn

  • U.S. Pharmacopeia
    U.S. Pharmacopeia Offering faster, simpler access to a wealth of information about the quality of drugs, foods and dietary supplements, USP has launched a new website at www.usp.org. Redesigned to provide updated and expanded content, as well as greatly enhanced navigation, the new site provides quick access to resources tailored to volunteers, manufacturers, practitioners, patients, consumers and regulators.
    56 minutes ago
  • U.S. Pharmacopeia
  • U.S. Pharmacopeia
    U.S. Pharmacopeia Furthering its commitment to advancing public health, USP has named Reema Jweied-Guegel as vice president of development. In this role, Ms. Jweied-Guegel will lead the newly formed development department, which is tasked with making USP’s standards broadly available to all countries and obtaining philanthropic funding to support current and future global health initiatives.
    2 days ago
  • U.S. Pharmacopeia
    U.S. Pharmacopeia has a new Scientist IV
    Huiping Tu

    Huiping Tu is now Scientist IV

    9 days ago
  • U.S. Pharmacopeia
    U.S. Pharmacopeia USP will be hosting a webinar providing compendial guidance and requirements for the selection of suitable balances and appropriate weighing procedures needed for performing laboratory analyses.
    15 days ago
  • U.S. Pharmacopeia
    U.S. Pharmacopeia USP will be hosting a Pharmacopeial Education webinar exploring a variety of strategies to demonstrate compliance of drug products with the requirements for Residual Solvents, per General Chapter <467>. Discussions will include use of alternative procedures and ways to avoid or minimize routine testing. We will discuss the scope of General Chapter <467>, including which products must comply with the requirements and which do not fall under the purview of the Chapter.
    15 days ago
  • U.S. Pharmacopeia
    U.S. Pharmacopeia has a new Scientist III
    Lucy Botros

    Lucy Botros is now Scientist III

    18 days ago
  • U.S. Pharmacopeia
    U.S. Pharmacopeia USP is hosting a webinar on Protein Glycosylation to highlight the strategy that USP is taking to include glycan analysis, explaining the content of the chapters and how these will be linked to suitable reference standards.
    22 days ago
  • U.S. Pharmacopeia
    U.S. Pharmacopeia Info, including the preliminary agenda for June's workshop on dissolution is now available. Be sure to RSVP on LinkedIn (and register!) so you don't miss out on important updates and news about the workshop.
    24 days ago
  • U.S. Pharmacopeia
    U.S. Pharmacopeia We now have info on USP's upcoming workshop on probiotics available on LinkedIn as well. Be sure to RSVP (and register!) to stay on top of updates and news about the workshop! http://linkd.in/zdJUjE
    1 month ago

See all activity »

Type
Nonprofit
Company Size
501-1000 employees
Website
http://www.usp.org
Industry
Pharmaceuticals
Founded
1820

Headquarters

12601 Twinbrook Parkway Rockville, Maryland 20852 United States
U.S. Pharmacopeia Headquarters

This LinkedIn Company Profile was created by LinkedIn and is about U.S. Pharmacopeia. This page is not endorsed by or affiliated with U.S. Pharmacopeia. For questions regarding LinkedIn Company Profiles contact us.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions